SynthesisOncotarget2017

Efficacy and safety of BRAF inhibition alone versus combined BRAF and MEK inhibition in melanoma: a meta-analysis of randomized controlled trials.

Mengdong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.